Showing 681 - 700 results of 778 for search '"Prostate cancer"', query time: 0.06s Refine Results
  1. 681

    Fenômeno sexless marriage, câncer de próstata e bioética by Bruno Vilalva Mestrinho, Vitória Marra da Motta Vilalva Mestrinho, Renata Verna Leal de Oliveira

    Published 2025-01-01
    “…Consultaram-se as bases PubMed, SciELO e Google Scholar e sites de grande circulação, por meio dos descritores prostate cancer, relationship intimacy, partner, sexless marriage e treatment. …”
    Get full text
    Article
  2. 682

    Computational evaluation on spectroscopic (FT-IR, Raman), electronic and biological, and NLO properties of cirsilineol by DFT, ADMET, and molecular docking method by Tirth Raj Paneru, Poonam Tandon, Bhawani Datt Joshi

    Published 2025-01-01
    “…This study aims to investigate the spectroscopic, electronic, and biological properties of drugs and predict their suitability for drug-like candidates to inhibit prostate cancer. The computational evaluation was performed with density functional theory (DFT) at B3LYP/6−311++G(d,p) level of theory and drug-like characteristics rendered from ADMET analysis. …”
    Get full text
    Article
  3. 683

    Computational evaluation on spectroscopic (FT-IR, Raman), electronic and biological, and NLO properties of cirsilineol by DFT, ADMET, and molecular docking method by Tirth Raj Paneru, Poonam Tandon, Bhawani Datt Joshi

    Published 2025-01-01
    “…This study aims to investigate the spectroscopic, electronic, and biological properties of drugs and predict their suitability for drug-like candidates to inhibit prostate cancer. The computational evaluation was performed with density functional theory (DFT) at B3LYP/6−311++G(d,p) level of theory and drug-like characteristics rendered from ADMET analysis. …”
    Get full text
    Article
  4. 684

    Chronic calcified subdural hematoma masquerading as hemorrhagic extra-axial mass: A case report and brief review of the literature by Musharaf Khan, DO, Subtain Ali, MD, Joe T. Joseph, MD, Sanjay Bhatia, MBBS, MS, MBChB, MBA, FAANS, DABA, Dhairya A. Lakhani, MD

    Published 2025-03-01
    “…A 73-year-old male with a history of prostate cancer, hypertension, and hyperlipidemia presented with vision changes and mild papilledema. …”
    Get full text
    Article
  5. 685
  6. 686

    Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication by Anastasia Thanopoulou, Demetrios Pectasides

    Published 2014-01-01
    “…Patients with cancer were older and more frequently smokers. Prostate cancer was the most frequent (24.0%) type. In T1DM cancer comorbidity was 3.0%. …”
    Get full text
    Article
  7. 687

    Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? by Athina Kladi-Skandali, Kleita Michaelidou, Andreas Scorilas, Konstantinos Mavridis

    Published 2015-01-01
    “…The most prominent example of lncRNAs application in routine clinical practice is PCA3, a FDA-approved biomarker for prostate cancer. Regarding digestive system malignancies, the oncogenic HOTAIR is one of the most widely studied lncRNAs in the preclinical level and has already been identified as a potent prognostic marker for major malignancies of the gastrointestinal tract. …”
    Get full text
    Article
  8. 688

    General Approach to Identifying Potential Targets for Cancer Imaging by Integrated Bioinformatics Analysis of Publicly Available Genomic Profiles by Yongliang Yang, S. James Adelstein, Amin I. Kassis

    Published 2011-03-01
    “…We provide herein an example of identifying a tumor cell growth and proliferation subnetwork for prostate cancer. This systematic mining approach can be broadly applied to identify imaging or therapeutic targets for other human diseases.…”
    Get full text
    Article
  9. 689

    Quantitative Assessment of Photoneutron-induced Secondary Radiation Dose in Prostate Treatment Using an 18 MV Medical Linear Accelerator: A Monte Carlo Study by Mustapha Assalmi, Abdullah Alshreef, EL Yamani Diaf, Assia Arectout, Nicholas Ade, El Hassan El Berhdadi

    Published 2024-12-01
    “…Purpose: This study aims to quantify the secondary radiation dose caused by photoneutrons during prostate cancer treatment using an 18 MV medical linear accelerator (LINAC) through Monte Carlo simulations and experimental validation. …”
    Get full text
    Article
  10. 690

    Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types by Jack D. Burton, David M. Goldenberg, Rosalyn D. Blumenthal

    Published 2008-01-01
    “…While preclinical activity has been observed in many cancer types, clinical activity has been observed only in pilot and phase II trials in liposarcoma and prostate cancer. Most studies address agonist compounds, with substantially fewer reports on anticancer effects of PPARγ antagonists. …”
    Get full text
    Article
  11. 691

    Treatment of Urethral Strictures from Irradiation and Other Nonsurgical Forms of Pelvic Cancer Treatment by Iyad Khourdaji, Jacob Parke, Avinash Chennamsetty, Frank Burks

    Published 2015-01-01
    “…Radiation therapy (RT), external beam radiation therapy (EBRT), brachytherapy (BT), photon beam therapy (PBT), high intensity focused ultrasound (HIFU), and cryotherapy are noninvasive treatment options for pelvic malignancies and prostate cancer. Though effective in treating cancer, urethral stricture disease is an underrecognized and poorly reported sequela of these treatment modalities. …”
    Get full text
    Article
  12. 692

    Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q by Sukesh Manthri, Naresh K. Vasireddy, Sindhura Bandaru, Swati Pathak

    Published 2018-01-01
    “…A 73-year-old male with a history of prostate cancer presented to the hospital for evaluation of bleeding gums. …”
    Get full text
    Article
  13. 693

    NMD Microarray Analysis for Rapid Genome-Wide Screen of Mutated Genes in Cancer by Maija Wolf, Henrik Edgren, Aslaug Muggerud, Sami Kilpinen, Pia Huusko, Therese Sørlie, Spyro Mousses, Olli Kallioniemi

    Published 2005-01-01
    “…Such a “mutatomics” screening of prostate cancer cell lines led to the identification of inactivating mutations in the EPHB2 gene. …”
    Get full text
    Article
  14. 694

    Semantic Modeling for SNPs Associated with Ethnic Disparities in HapMap Samples by HyoYoung Kim, Won Gi Yoo, Junhyung Park, Heebal Kim, Byeong-Chul Kang

    Published 2014-03-01
    “…Our semantic modeling for ethnicity-specific SNPs showed interesting results in the three categories, including three diseases ("AIDS-associated nephropathy," "Hypertension," and "Pelvic infection"), one drug ("Methylphenidate"), and five pathways ("Hemostasis," "Systemic lupus erythematosus," "Prostate cancer," "Hepatitis C virus," and "Rheumatoid arthritis"). …”
    Get full text
    Article
  15. 695

    Role of S100 Proteins in Colorectal Carcinogenesis by Paula Moravkova, Darina Kohoutova, Stanislav Rejchrt, Jiri Cyrany, Jan Bures

    Published 2016-01-01
    “…Colorectal cancer is the third most common cancer in men (after lung and prostate cancer) and the second most frequent cancer in women (after breast cancer) worldwide. …”
    Get full text
    Article
  16. 696

    Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy by Kamyar Ghabili, Nathan Paulson, Jamil S. Syed, Cayce B. Nawaf, Ghazal Khajir, Darryl T. Martin, John Onofrey, Michael S. Leapman, Angelique Levi, Jeffrey C. Weinreb, Peter A. Humphrey, Preston C. Sprenkle

    Published 2021-01-01
    “…In a man on active surveillance for low-risk prostate cancer, a doubling of the Decipher biopsy score within genomic low-risk category from first to the second biopsy related to biopsy reclassification to Gleason grade group 4 on the third biopsy. …”
    Get full text
    Article
  17. 697

    Regulatory Role of the RUNX2 Transcription Factor in Lung Cancer Apoptosis by Camila Bernal, Andrea Otalora, Alejandra Cañas, Alfonso Barreto, Karol Prieto, Martin Montecino, Adriana Rojas

    Published 2022-01-01
    “…Current studies have confirmed that RUNX2 is closely related to the proliferation, invasion, and bone metastasis of multiple cancer types, such as osteosarcoma, breast cancer (BC), prostate cancer, gastric cancer, colorectal cancer, and lung cancer. …”
    Get full text
    Article
  18. 698

    Review of presentations and radiotherapy outcomes of patients with malignant spinal cord compression by Louisa M. Mbokazi, Sheynaz Bassa, Krishanthavathie Pillay

    Published 2025-01-01
    “…Results: Breast and prostate cancer were the most frequent primary disease sites. …”
    Get full text
    Article
  19. 699

    Cancer Mortality by Ethnicity in Colombia Between 2011 and 2022: A Population-Based Study by Maria Camila Urrea Suescun, Isabel C. Garcés-Palacio, Amr S. Soliman

    Published 2025-02-01
    “…Compared to the Mestizo population, Raizales and Afro-Colombians experienced disproportionately higher age-standardized mortality rates due to prostate cancer (26.6/100,000 and 8.6/100,000 vs. 8.1/100,000), and for Raizales and Rom breast cancer (14.0/100,000 and 103.2/100,000 vs. 9.1/100,000).ConclusionThe disparities in cancer mortality in ethnic minorities in Colombia call for investigating cancer etiology and access to care among the Rom and the Raizal populations.…”
    Get full text
    Article
  20. 700

    Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010 by Simeng Gao, Shaojie Li, Baofang Wu, Jiayin Wang, Sijuan Ding, Zhaohui Tang

    Published 2025-01-01
    “…Abstract Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. …”
    Get full text
    Article